N C Thomson

Summary

Affiliation: University of Glasgow
Country: UK

Publications

  1. ncbi Identification and management of adults with asthma prone to exacerbations: can we do better?
    Neil C Thomson
    Respiratory Medicine Section, Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK
    BMC Pulm Med 8:27. 2008
  2. ncbi Asthma in smokers: challenges and opportunities
    Neil C Thomson
    Division of Immunology, Infection and Inflammation, Department of Respiratory Medicine, University of Glasgow, Gartnavel General Hospital, Glasgow, UK
    Curr Opin Pulm Med 15:39-45. 2009
  3. ncbi Asthma therapy: theophylline
    N C Thomson
    University of Glasgow, Glasgow, United Kingdom
    Can Respir J 5:60A-3A. 1998
  4. ncbi The role of environmental tobacco smoke in the origins and progression of asthma
    Neil C Thomson
    Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, Western Infirmary and University of Glasgow, Glasgow G11 6NT, UK
    Curr Allergy Asthma Rep 7:303-9. 2007
  5. ncbi Asthma and cigarette smoking
    N C Thomson
    Dept of Respiratory Medicine, Division of Immunology, Infection and Inflammation, Western Infirmary and University of Glasgow, Glasgow, G11 6NT, UK
    Eur Respir J 24:822-33. 2004
  6. ncbi The influence of smoking on the treatment response in patients with asthma
    Neil C Thomson
    Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK
    Curr Opin Allergy Clin Immunol 5:57-63. 2005
  7. ncbi Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma
    E J Hothersall
    Respiratory Medicine Section, Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK
    Thorax 63:1070-5. 2008
  8. ncbi Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study
    M Spears
    Faculty of Medicine, University of Glasgow, Glasgow, UK
    Eur Respir J 33:1010-7. 2009
  9. ncbi Role of symptoms and lung function in determining asthma control in smokers with asthma
    R Chaudhuri
    Department of Respiratory Medicine, University of Glasgow, Glasgow, UK
    Allergy 63:132-5. 2008
  10. ncbi Bronchodilatory effect of the PPAR-gamma agonist rosiglitazone in smokers with asthma
    M Spears
    Department of Respiratory Medicine, Faculty of Medicine, University of Glasgow, Glasgow, UK
    Clin Pharmacol Ther 86:49-53. 2009

Collaborators

Detail Information

Publications52

  1. ncbi Identification and management of adults with asthma prone to exacerbations: can we do better?
    Neil C Thomson
    Respiratory Medicine Section, Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK
    BMC Pulm Med 8:27. 2008
    ....
  2. ncbi Asthma in smokers: challenges and opportunities
    Neil C Thomson
    Division of Immunology, Infection and Inflammation, Department of Respiratory Medicine, University of Glasgow, Gartnavel General Hospital, Glasgow, UK
    Curr Opin Pulm Med 15:39-45. 2009
    ..We summarize recent evidence supporting the adverse effects of smoking in asthma and consider strategies to manage these patients...
  3. ncbi Asthma therapy: theophylline
    N C Thomson
    University of Glasgow, Glasgow, United Kingdom
    Can Respir J 5:60A-3A. 1998
    ..The relative efficacy and side effect profile of oral theophylline versus oral leukotriene modulators as an 'add on' therapy remain to be established...
  4. ncbi The role of environmental tobacco smoke in the origins and progression of asthma
    Neil C Thomson
    Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, Western Infirmary and University of Glasgow, Glasgow G11 6NT, UK
    Curr Allergy Asthma Rep 7:303-9. 2007
    ..Workplace smoking restrictions and reduced smoking in the home may lower the prevalence of asthma, improve asthma control, and reduce the use of medical services in both children and adults who are exposed to ETS...
  5. ncbi Asthma and cigarette smoking
    N C Thomson
    Dept of Respiratory Medicine, Division of Immunology, Infection and Inflammation, Western Infirmary and University of Glasgow, Glasgow, G11 6NT, UK
    Eur Respir J 24:822-33. 2004
    ..Alternative or additional therapies to inhaled corticosteroids are needed for asthmatic patients who are unable to quit smoking...
  6. ncbi The influence of smoking on the treatment response in patients with asthma
    Neil C Thomson
    Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK
    Curr Opin Allergy Clin Immunol 5:57-63. 2005
    ..We also consider the effect smoking has on other drugs commonly used to treat patients with asthma...
  7. ncbi Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma
    E J Hothersall
    Respiratory Medicine Section, Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK
    Thorax 63:1070-5. 2008
    ..A study was undertaken to test the hypothesis that atorvastatin added to inhaled corticosteroids improves lung function and airway inflammation in atopic adults with asthma...
  8. ncbi Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study
    M Spears
    Faculty of Medicine, University of Glasgow, Glasgow, UK
    Eur Respir J 33:1010-7. 2009
    ..Larger trials are required to extend and confirm these findings...
  9. ncbi Role of symptoms and lung function in determining asthma control in smokers with asthma
    R Chaudhuri
    Department of Respiratory Medicine, University of Glasgow, Glasgow, UK
    Allergy 63:132-5. 2008
    ..Cigarette smoking in asthma increases the severity and accelerates the decline in lung function. The relative role of symptoms and lung function in determining asthma control in smokers with asthma is not known...
  10. ncbi Bronchodilatory effect of the PPAR-gamma agonist rosiglitazone in smokers with asthma
    M Spears
    Department of Respiratory Medicine, Faculty of Medicine, University of Glasgow, Glasgow, UK
    Clin Pharmacol Ther 86:49-53. 2009
    ..24 l/s, P = 0.030) as compared with inhaled beclometasone dipropionate. Further trials using PPAR-gamma agonists in steroid-resistant airway disease are indicated...
  11. ncbi Smoking and airway inflammation in patients with mild asthma
    G W Chalmers
    Department of Respiratory Medicine, Western Infirmary, Glasgow, UK
    Chest 120:1917-22. 2001
    ....
  12. ncbi Immuno-regulatory cytokines in asthma: IL-15 and IL-13 in induced sputum
    M Komai-Koma
    Department of Immunology, Western Infirmary, Glasgow, UK
    Clin Exp Allergy 31:1441-8. 2001
    ..The macrophage-derived cytokine, interleukin (IL)-15 has a number of T cell regulatory properties which might be of relevance to asthma and its treatment...
  13. ncbi Serum and sputum neurotrophin levels in chronic persistent cough
    R Chaudhuri
    Departments of Respiratory Medicine, University of Glasgow and Western Infirmary, Glasgow, UK
    Clin Exp Allergy 35:949-53. 2005
    ..34, P=0.002). CONCLUSION: NTs are not elevated in induced sputum or serum of subjects with chronic persistent cough. This implies that NTs do not have a central role in perpetuating airway inflammation in chronic persistent cough...
  14. ncbi Systemic sensitivity to corticosteroids in smokers with asthma
    E Livingston
    Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, University of Glasgow and Western Infirmary, Glasgow, G11 6NT, UK
    Eur Respir J 29:64-71. 2007
    ..This finding suggests that the insensitivity to corticosteroids in smokers with asthma affects tissue sites other than the airways...
  15. ncbi Peripheral blood dendritic cell subtypes are significantly elevated in subjects with asthma
    M Spears
    Department of Respiratory Medicine, Institute of Infection, Immunity and Inflammation, Gartnavel General Hospital, University of Glasgow, Glasgow, UK
    Clin Exp Allergy 41:665-72. 2011
    ..Smokers with asthma display altered therapeutic behaviour and a reduction in endobronchial DC CD83 expression compared with non-smokers with asthma. No information is available on the impact of smoking on peripheral blood DC profiles...
  16. ncbi High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity
    S A Little
    Department of Respiratory Medicine, Western Infirmary, Glasgow, UK
    Thorax 57:247-53. 2002
    ..CONCLUSIONS: The airway wall is thickened in more severe asthma and is associated with gas transfer coefficient. This thickening does not relate directly to irreversible airflow obstruction as measured with FEV1...
  17. ncbi Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma
    J E M Tomlinson
    Department of General Practice, University of Glasgow, Glasgow, UK
    Thorax 60:282-7. 2005
    ..The disparity of the response between smokers and non-smokers appears to be reduced with high dose inhaled corticosteroid. These findings have important implications for the management of individuals with mild asthma who smoke...
  18. ncbi No effect of the oral neutral endopeptidase inhibitor candoxatril, on bronchomotor tone and histamine reactivity in asthma
    R M Angus
    Dept of Respiratory Medicine, Western Infirmary, Glasgow, UK
    Eur Respir J 7:1084-9. 1994
    ..17 (0.25-25.8) and 0.93 (0.13-32) mg.ml-1, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)..
  19. ncbi The effect of acute alteration in oxygen tension on the bronchodilator response to salbutamol in vitro and in vivo in man
    K D Dagg
    Department of Respiratory Medicine, North Glasgow Hospitals University NHS Trust, Glasgow, G12 0YN, UK
    Pulm Pharmacol Ther 14:99-105. 2001
    ..We conclude that acute hypoxia attenuates airway smooth muscle relaxation in response to salbutamol in vitro but has no effect on salbutamol-induced bronchodilation in in-patients with asthma...
  20. ncbi Effect of improved home ventilation on asthma control and house dust mite allergen levels
    G R Wright
    Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK
    Allergy 64:1671-80. 2009
    ..We tested the hypothesis that a domestic mechanical heat recovery ventilation system (MHRV), in addition to allergen avoidance measures, can improve asthma control by attenuating re-colonization rates...
  21. ncbi Effect of infused angiotensin II on the bronchoconstrictor activity of inhaled endothelin-1 in asthma
    G W Chalmers
    Department of Respiratory Medicine, West Glasgow Hospitals University NHS Trust, Scotland, UK
    Chest 115:352-6. 1999
    ..We wished to examine any potentiation of the bronchoconstrictor activity of inhaled ET-1 by infused Ang II at subbronchoconstrictor doses...
  22. ncbi Interleukin-18 levels in induced sputum are reduced in asthmatic and normal smokers
    A McKay
    Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK
    Clin Exp Allergy 34:904-10. 2004
    ..CONCLUSIONS: IL-18 is detectable in induced sputum samples from both asthmatic and normal subjects. Cigarette smoking significantly reduces sputum IL-18 levels. This effect is more pronounced in asthmatics than in normal subjects...
  23. ncbi Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease
    M Spears
    Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK
    Clin Exp Allergy 36:1494-504. 2006
    ..We review the evidence from these experimental models and their applicability to asthma and COPD and the requirements for future clinical and experimental research...
  24. ncbi Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma
    G W Chalmers
    Departments of Respiratory Medicine and Immunology, Western Infirmary, Glasgow G11 6NT, UK
    Thorax 57:226-30. 2002
    ..CONCLUSIONS: Active cigarette smoking impairs the efficacy of short term inhaled corticosteroid treatment in mild asthma. This finding has important implications for the management of patients with mild asthma who smoke...
  25. ncbi Effects of smoking cessation on lung function and airway inflammation in smokers with asthma
    Rekha Chaudhuri
    FRCP, Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, University of Glasgow and Western Infirmary, Glasgow G11 6NT, UK
    Am J Respir Crit Care Med 174:127-33. 2006
    ..These findings highlight the importance of smoking cessation in asthma...
  26. ncbi Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice
    M Komai-Koma
    Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK
    Allergy 67:1118-26. 2012
    ..IL-33 administration increases serum IgE in mice with unknown mechanism. We tested the hypothesis that IL-33 provides an antigen-independent stimulus for IgE production and mast cell degranulation...
  27. ncbi Sputum endothelin-1 is increased in cystic fibrosis and chronic obstructive pulmonary disease
    G W Chalmers
    Dept of Respiratory Medicine, West Glasgow Hospitals University NHS Trust, UK
    Eur Respir J 13:1288-92. 1999
    ..The role of endothelin-1 in contributing to airflow obstruction through bronchoconstriction and mitogenesis in cystic fibrosis needs now to be explored...
  28. ncbi Short and long-term effects of cigarette smoking independently influence exhaled nitric oxide concentration in asthma
    Charles P McSharry
    Department of Immunology, Division of Immunology, Infection and Inflammation, University of Glasgow, United Kingdom
    J Allergy Clin Immunol 116:88-93. 2005
    ..The fractional concentration of nitric oxide in exhaled breath (FeNO) is elevated in asthma. FeNO measurement has been proposed as a noninvasive index of disease activity. Cigarette smoking suppresses FeNO, which limits its use in smokers...
  29. ncbi Challenges of treating asthma in people who smoke
    Mark Spears
    Respiratory Medicine Section, Division of Immunology, Infection and Inflammation, Gartnavel General Hospital and University of Glasgow, Glasgow G12 OYN, UK
    Expert Rev Clin Immunol 6:257-68. 2010
    ..This review examines the range of adverse health effects of smoking in asthma, the inflammatory mechanisms that may influence the efficacy of current drugs and discusses potential future therapeutic directions...
  30. ncbi Nerve growth factor in serum and lymphocyte culture in pigeon fanciers' acute hypersensitivity pneumonitis
    Charles P McSharry
    Department of Immunology, Division of Immunology, Infection and Inflammation, University of Glasgow, UK
    Chest 130:37-42. 2006
    ..Nerve growth factor (NGF) is a neurotrophic cytokine with immunomodulatory activity. NGF contributes to neurogenic inflammation and has been described in asthma and idiopathic pulmonary fibrosis...
  31. ncbi Treating patients with respiratory disease who smoke
    Georgina Braganza
    Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK
    Ther Adv Respir Dis 2:95-107. 2008
    ....
  32. ncbi Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma
    Stuart A Little
    Department of Respiratory Medicine, University of Glasgow, Glasgow, Scotland, United Kingdom
    Am J Med 112:446-52. 2002
    ..The negative associations of sputum neutrophil count and activation with maximal FEV(1) suggest that neutrophils may be involved in the pathophysiology of irreversible airflow obstruction in asthma...
  33. ncbi Assessment of the presence of occult myocardial infarction in chronic obstructive pulmonary disease using contrast-enhanced cardiac magnetic resonance imaging
    C Aengus Murphy
    Cardiology Department, Western Infirmary, University of Glasgow, Glasgow, UK
    Respiration 78:263-9. 2009
    ..Chronic obstructive pulmonary disease (COPD) has been identified as a risk factor for ischaemic heart disease, independent of smoking history, and inflammation is thought to play a role...
  34. ncbi Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments
    E J Cameron
    Respiratory Medicine, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK
    Clin Exp Allergy 42:1302-12. 2012
    ..Potentially novel macrolides may overcome a significant barrier to the use of this type of drug for the long-term treatment of chronic inflammatory airway diseases...
  35. ncbi Potential therapeutic role for statins in respiratory disease
    E Hothersall
    Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, Western Infirmary and University of Glasgow, Glasgow G11 6NT, UK
    Thorax 61:729-34. 2006
    ..This review considers the evidence for the anti-inflammatory properties of statins in the lung, and how these effects are being applied to research into the role of statins as a novel treatment of respiratory diseases...
  36. ncbi Effects of angiotensin II on remodelling of the airway and the vasculature in the rat
    S G Ramsay
    Department of Respiratory Medicine, West Glasgow Hospitals University NHS Trust, Glasgow, Scotland, U K
    Clin Sci (Lond) 98:1-7. 2000
    ..Therefore a 2-week infusion of angiotensin II increases blood pressure and DNA synthesis in the mesenteric arteries, but does not cause airway remodelling, in the rat...
  37. ncbi In vivo and in vitro human airway responsiveness to leukotriene D4 in patients without asthma
    J A Roberts
    Department of Respiratory Medicine, Western Infirmary, Glasgow, Scotland
    J Allergy Clin Immunol 80:688-94. 1987
    ....
  38. ncbi Impact of smoking on asthma therapy: a critical review of clinical evidence
    Eric Livingston
    Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK
    Drugs 65:1521-36. 2005
    ..Smoking cessation measures must be given a high priority in individuals with asthma who smoke...
  39. ncbi Asthma: ten myths debunked
    Gillian Vallance
    Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, University of Glasgow
    Practitioner 248:844-7. 2004
  40. ncbi Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma
    Rekha Chaudhuri
    Department of Respiratory Medicine, University of Glasgow, Glasgow, UK
    Am J Respir Crit Care Med 168:1308-11. 2003
    ..1; CI, 2.3, 56; p = 0.04 and 52.4; CI, 26, 79; p = 0.003, respectively), but not in FEV1 or asthma control score. We conclude that active smoking impairs the efficacy of short-term oral corticosteroid treatment in chronic asthma...
  41. ncbi Managing chronic obstructive pulmonary disease
    Eric Livingston
    Department of Respiratory Medicine, University of Glasgow, Western Infirmary, Glasgow
    Practitioner 247:289, 292, 296 passim. 2003
  42. ncbi Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough
    Rekha Chaudhuri
    Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, University of Glasgow and Western Infirmary, Glasgow G11 6NT, Scotland, United Kingdom
    J Allergy Clin Immunol 113:1063-70. 2004
    ..LTB(4), Cys-LT, PGE(2), IL-8, myeloperoxidase, and TNF-alpha levels are unaltered by this therapy. This raises the possibility that drugs targeted to reduce the effects of these mediators might be of benefit in chronic persistent cough...
  43. ncbi Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease
    Neil C Barnes
    Department of Respiratory Medicine, London Chest Hospital, London, UK
    Am J Respir Crit Care Med 173:736-43. 2006
    ....
  44. ncbi A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma
    Anne McKay
    Division of Immunology, Infection, and Inflammation, Section of Respiratory Medicine, University of Glasgow, Glasgow, United Kingdom
    J Immunol 172:2903-8. 2004
    ..Simvastatin treatment did not alter serum total IgE or OVA-specific IgG1 and IgG2a levels. These data demonstrate the therapeutic potential of statin-sensitive pathways in allergic airways disease...
  45. ncbi Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis
    Manish Patel
    Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK
    Eur J Immunol 35:3581-90. 2005
    ..Our results therefore provide direct evidence that GITR can modulate both Th1- and Th2-mediated inflammatory diseases, and may be a potential target for therapeutic intervention...
  46. ncbi Asthma control during the year after bronchial thermoplasty
    Gerard Cox
    St Joseph s Healthcare, McMaster University, Hamilton, ON, Canada
    N Engl J Med 356:1327-37. 2007
    ..Bronchial thermoplasty is a bronchoscopic procedure to reduce the mass of airway smooth muscle and attenuate bronchoconstriction. We examined the effect of bronchial thermoplasty on the control of moderate or severe persistent asthma...
  47. ncbi Smokers with asthma: what are the management options?
    Neil C Thomson
    Am J Respir Crit Care Med 175:749-50. 2007
  48. ncbi Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma
    Umesh G Lalloo
    Nelson R Mandela School of Medicine, University of Natal, Durban, South Africa
    Chest 123:1480-7. 2003
    ....
  49. ncbi Stepping down inhaled corticosteroids in asthma: randomised controlled trial
    Gillian Hawkins
    Department of General Practice, University of Glasgow, Glasgow G12 0RR
    BMJ 326:1115. 2003
    ..CONCLUSIONS: By adopting a stepdown approach to the use of inhaled steroids at high doses in asthma a reduction in the dose can be achieved without compromising asthma control...
  50. ncbi Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma
    Ian D Pavord
    Glenfield General Hospital, University Hospitals of Leicester NHS Trust, Groby Road, Leicester LE3 9QP, United Kingdom
    Am J Respir Crit Care Med 176:1185-91. 2007
    ..Bronchial thermoplasty (BT) is designed to reduce airway smooth muscle and improve asthma control...
  51. ncbi Glucocorticoid receptor alpha:beta ratio in blood mononuclear cells is reduced in cigarette smokers
    Eric Livingston
    J Allergy Clin Immunol 114:1475-8. 2004
  52. ncbi Why is eosinophilic bronchitis not asthma?
    Neil C Thomson
    Am J Respir Crit Care Med 170:4-5. 2004